Log In
BCIQ
Print this Print this
 

CB-618

  Manage Alerts
Collapse Summary General Information
Company Merck & Co. Inc.
DescriptionBeta lactamase inhibitor
Molecular Target Beta lactamase (LACTB)
Mechanism of ActionBeta lactamase inhibitor
Therapeutic Modality 
Latest Stage of DevelopmentPhase I
Standard IndicationBacterial infection
Indication DetailsTreat bacterial infections
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today